George A. Samuel III - Feb 11, 2022 Form 4 Insider Report for Lineage Cell Therapeutics, Inc. (LCTX)

Role
General Counsel/Secretary
Signature
/s/ Grant Harbert, as Attorney-in Fact
Stock symbol
LCTX
Transactions as of
Feb 11, 2022
Transactions value $
$0
Form type
4
Date filed
2/15/2022, 06:45 PM
Previous filing
Sep 2, 2021
Next filing
Mar 11, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LCTX Restricted Stock Units Award $0 +24.3K $0.00 24.3K Feb 11, 2022 Common Shares 24.3K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units under Lineage's 2021 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one Common Share.
F2 Subject to continuous service, vests in four equal annual installments beginning on February 11, 2023.